Publication | Closed Access

The protective effect of losartan in the nephropathy of the diabetic rat includes the control of monoamine oxidase type A activity

Diabetic RatRenal FunctionMedicineChronic Kidney DiseasePhysiologyDiabetesDiabetic Kidney DiseaseMonoamine OxidasePharmacologyProtective EffectNephrologyKidney ResearchOxidative Stress